Last reviewed · How we verify
Acute monocytic leukemia
Approved treatments
- Cyclophosphamid · Zhejiang University
- Cytoxan (Lyophilized) · Baxter
Cyclophosphamide cross-links tumor cell DNA and interferes with malignant cell growth through active alkylating metabolites. - Cytoxan (Lyophilized) · Baxter
Cytoxan works by interfering with the DNA replication process in rapidly dividing cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute monocytic leukemia patent landscape — cliff calendar, originator estates, attackable patents
- Acute monocytic leukemia treatment landscape brief
- Acute monocytic leukemia treatment updates RSS
Frequently asked questions about Acute monocytic leukemia
What drugs treat Acute monocytic leukemia?
Tracked treatments include Cyclophosphamid, Cytoxan (Lyophilized).
What is the treatment for Acute monocytic leukemia?
Standard treatment for Acute monocytic leukemia includes Cyclophosphamid, Cytoxan (Lyophilized). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute monocytic leukemia patent cliff · Acute monocytic leukemia CI report
- Treatment: Cyclophosphamid · Zhejiang University
- Treatment: Cytoxan (Lyophilized) · Baxter
- Treatment: Cytoxan (Lyophilized) · Baxter
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing